This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Nihon University, Sbi Pharmaceuticals Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016
Title: Akihiro Noda: Innovator in Sepsis Therapeutics
Introduction
Akihiro Noda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, particularly in the development of therapeutic agents for sepsis. His innovative work has the potential to improve treatment outcomes for patients suffering from this serious condition.
Latest Patents
Noda holds a patent for a prophylactic agent and therapeutic agent for sepsis. This invention provides a sepsis therapeutic drug useful for both prophylaxis and treatment of sepsis. The active ingredient in this agent is 5-aminolevulinic acid (5-ALA) or a derivative thereof, along with pharmacologically acceptable salts. The formulation may also include metal-containing compounds, such as ferrous sodium citrate, to enhance its efficacy.
Career Highlights
Throughout his career, Akihiro Noda has worked with notable organizations, including Sbi Pharmaceuticals Co., Ltd. and Nihon University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in therapeutic innovations.
Collaborations
Noda has collaborated with esteemed colleagues, including Kosaku Kinoshita and Katsuhisa Tanjoh. These partnerships have contributed to the advancement of his research and the development of effective therapeutic solutions.
Conclusion
Akihiro Noda's contributions to the field of sepsis treatment through his innovative patent demonstrate his commitment to improving healthcare. His work continues to pave the way for advancements in therapeutic agents, potentially benefiting countless patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile